Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator "FASTFlo tPA"

Completed

Phase 1 Results N/A

Eligibility Criteria

Inclusion Criteria

- Ischemic stroke
- NIHSS between 5-22
- Persistent clinical deficits following administration of rt-PA

Exclusion Criteria

- Planned thrombectomy
- Aortic pathology
- Severe heart disease
- Other conditions the doctor will assess